Analysts expect CVS Health Corporation (NYSE:CVS) to post $1.90 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Seventeen analysts have issued estimates for CVS Health Corporation’s earnings, with the lowest EPS estimate coming in at $1.88 and the highest estimate coming in at $1.93. CVS Health Corporation reported earnings of $1.71 per share during the same quarter last year, which indicates a positive year-over-year growth rate of 11.1%. The company is expected to issue its next earnings results on Thursday, February 8th.

According to Zacks, analysts expect that CVS Health Corporation will report full-year earnings of $5.89 per share for the current fiscal year, with EPS estimates ranging from $5.84 to $5.92. For the next financial year, analysts expect that the business will post earnings of $6.34 per share, with EPS estimates ranging from $6.23 to $6.41. Zacks Investment Research’s EPS averages are a mean average based on a survey of research firms that cover CVS Health Corporation.

CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.01. CVS Health Corporation had a return on equity of 16.96% and a net margin of 2.77%. The business had revenue of $46.18 billion for the quarter, compared to the consensus estimate of $46.17 billion. During the same period last year, the business earned $1.64 EPS. The firm’s revenue was up 3.5% compared to the same quarter last year.

CVS has been the topic of several recent analyst reports. Loop Capital cut their price objective on CVS Health Corporation from $83.00 to $73.00 and set a “hold” rating for the company in a research report on Tuesday. Jefferies Group LLC cut their price objective on CVS Health Corporation from $86.00 to $76.00 and set a “hold” rating for the company in a research report on Tuesday. Needham & Company LLC reiterated a “hold” rating on shares of CVS Health Corporation in a research report on Sunday, September 10th. Oppenheimer Holdings, Inc. reiterated a “buy” rating and issued a $95.00 price objective on shares of CVS Health Corporation in a research report on Monday, October 9th. Finally, TheStreet downgraded CVS Health Corporation from a “b-” rating to a “c+” rating in a research report on Tuesday, October 31st. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $85.82.

In related news, insider Larry J. Merlo sold 241,150 shares of the stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $83.07, for a total transaction of $20,032,330.50. Following the sale, the insider now owns 299,255 shares of the company’s stock, valued at $24,859,112.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Thomas M. Moriarty sold 90,267 shares of the stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $79.61, for a total value of $7,186,155.87. Following the sale, the executive vice president now directly owns 70,102 shares in the company, valued at approximately $5,580,820.22. The disclosure for this sale can be found here. In the last quarter, insiders have sold 716,625 shares of company stock worth $58,318,431. 0.61% of the stock is owned by corporate insiders.

Hedge funds have recently modified their holdings of the business. Horan Capital Advisors LLC. boosted its holdings in shares of CVS Health Corporation by 3.2% in the 2nd quarter. Horan Capital Advisors LLC. now owns 32,115 shares of the pharmacy operator’s stock valued at $2,584,000 after purchasing an additional 1,000 shares in the last quarter. Community Bank N.A. boosted its holdings in shares of CVS Health Corporation by 7.3% during the 2nd quarter. Community Bank N.A. now owns 19,976 shares of the pharmacy operator’s stock valued at $1,608,000 after acquiring an additional 1,362 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of CVS Health Corporation by 3.2% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock valued at $13,840,000 after acquiring an additional 5,478 shares in the last quarter. Midwest Investment Management LLC boosted its holdings in shares of CVS Health Corporation by 6.2% during the 2nd quarter. Midwest Investment Management LLC now owns 21,382 shares of the pharmacy operator’s stock valued at $1,720,000 after acquiring an additional 1,245 shares in the last quarter. Finally, Fiduciary Trust Co. boosted its holdings in shares of CVS Health Corporation by 1.2% during the 1st quarter. Fiduciary Trust Co. now owns 366,007 shares of the pharmacy operator’s stock valued at $28,732,000 after acquiring an additional 4,265 shares in the last quarter. 81.46% of the stock is currently owned by hedge funds and other institutional investors.

Shares of CVS Health Corporation (CVS) traded up $1.97 during trading hours on Wednesday, hitting $70.99. The stock had a trading volume of 10,299,801 shares, compared to its average volume of 6,615,108. CVS Health Corporation has a one year low of $66.45 and a one year high of $84.72. The firm has a market cap of $69,916.70, a price-to-earnings ratio of 12.09, a PEG ratio of 1.19 and a beta of 0.86. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.05 and a quick ratio of 0.56.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th were paid a $0.50 dividend. The ex-dividend date of this dividend was Monday, October 23rd. This represents a $2.00 annualized dividend and a yield of 2.82%. CVS Health Corporation’s dividend payout ratio is 41.32%.

COPYRIGHT VIOLATION NOTICE: “CVS Health Corporation (CVS) Expected to Announce Earnings of $1.90 Per Share” was first posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/cvs-health-corporation-cvs-expected-to-announce-earnings-of-1-90-per-share/1696245.html.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Get a free copy of the Zacks research report on CVS Health Corporation (CVS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.